HIFU outcomes in Germany after an average of 8 years of follow-up

Posted on March 4, 2013 by Sitemaster

Researchers at the University of Regensburg in Germany have just reported progression-free survival data from their 14-year experience of using high-intensity focused ultrasound (HIFU) in the treatment of localized prostate cancer. This research group was one of the first to start testing the use of HIFU in the treatment of prostate cancer. … READ MORE …

Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: , , , , , | 13 Comments »

Managing the side effects of ADT — a new review

Posted on February 27, 2013 by Sitemaster

According to a new analysis and review of recent, published data, the “numerous well recognized adverse effects” of androgen deprivation therapy (ADT) include “vasomotor flushing, loss of libido and impotence, fatigue, gynecomastia, anemia, osteoporosis and metabolic complications, as well as effects on cardiovascular health and bone density.” … READ MORE …

Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: , , , , | 6 Comments »

Delaying surgery for localized prostate cancer … what’s the downside?

Posted on July 30, 2012 by Sitemaster

A paper published in June this year in the Journal of Sexual Medicine suggests that delaying radical prostatectomy (RP) as a first-line treatment for localized prostate cancer has no significant effects on post-surgical pathology or mortality but may lead to higher risk for incontinence and erectile dysfunction. … READ MORE …

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , , , , | Leave a Comment »

Risks associated with implantation of “fiducial markers” before radiation therapy

Posted on March 4, 2012 by Sitemaster

It is becoming commonplace for men who are going to get external beam radiotherapy to treat their prostate cancer to have some form of “fiducial marker” (often tiny gold rods or balls) inserted into their prostates under transrectal ultrasound guidance to help ensure that the radiotherapy can be administered with the greatest possible accuracy. … READ MORE …

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , , , | 7 Comments »

Acute and mid-term side effects of high-dose, image-guided IMRT in first-line treatment of localized prostate cancer

Posted on November 21, 2011 by Sitemaster

Two recent papers have reported data relevant to the application of high-dose, image-guided, intensity-modulated forms of radiation therapy (IGRT/IMRT) in the first-line treatment of men with localized prostate cancer. … READ MORE …

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , , , , | 2 Comments »

A new way to look at side effects of first-line prostate cancer treatment

Posted on August 26, 2011 by Sitemaster

Academic research into the side effects of different treatments for localized prostate cancer have long been hampered by the lack of consistently used criteria for the assessment of those side effects at baseline and at defined time-periods post-treatment. … READ MORE …

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , , , , , | 3 Comments »

The role of exercise in prostate cancer management

Posted on June 27, 2011 by Sitemaster

Prostate cancer patients in general, but most especially men receiving androgen deprivation therapy (ADT), experience symptoms  and side effects of treatment that make it difficult to maintain their independence and quality of life. A recent review states that exercise may offset many of the side effects of ADT as well as those of the cancer itself. … READ MORE …

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , , | 2 Comments »

Treatment decision regret after radical prostatectomy

Posted on February 22, 2011 by Sitemaster

Prior studies have looked at the question of patient regret after election of specific types of treatment for localized prostate cancer. Unsurprisingly, this effect is not confined to patients in the USA, and a new study from Taiwan indicates that patient regret may be as high as 31 percent after radical prostatectomy (RP). … READ MORE …

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , , | Leave a Comment »

Side effects of surgery among patients diagnosed in the Göteborg screening trial

Posted on December 27, 2010 by Sitemaster

In July this year, we commented on the 14-year mortality data published by Hugosson et al. from the randomized, population-based, prostate cancer screening trial initiated in Göteborg, Sweden, in 1995. … READ MORE …

Filed under: Diagnosis, Management, Risk, Treatment | Tagged: , , , , , | 2 Comments »

Slightly fewer (severe) complications after IMRT compared to CRT

Posted on October 29, 2010 by Sitemaster

According to a media release from the University of Pennsylvania Health System, (and another from the American Society of Radiation Oncology [ASTRO]), intensity-modulated radiation therapy (IMRT) is associated with fewer complications than traditional, three-dimensional conformal radiation therapy (3D-CRT) in the treatment of non-metastatic prostate cancer. … READ MORE …

Filed under: Living with Prostate Cancer, Management | Tagged: , , , , , , | Leave a Comment »

Report provides final results of the TROPIC trial of cabazitaxel

Posted on October 2, 2010 by Sitemaster

Cabazitaxel (Jevtana®) has recently been approved in the USA for the treatment of men with castration-resistant prostate cancer who have progressive disease following treatment with standard first-line chemotherapy (docetaxel + prednisone). … READ MORE …

Filed under: Drugs in development, Management, Treatment, Uncategorized | Tagged: , , | 1 Comment »

Managing the side effects of long-term hormone therapy

Posted on December 1, 2009 by Sitemaster

Three recent publications are focused on the importance of the management of complications of long-term androgen deprivation therapy (ADT) in men with progressive or more advanced forms of prostate cancer. … READ MORE …

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , | Leave a Comment »

Prostate cancer news reports: Wednesday, September 23, 2009

Posted on September 23, 2009 by Sitemaster

Today’s news reports cover items on:

  • Extent and number of biopsy cores and eligibility for active surveillance
  • Intermittent vs. complete androgen deprivation
  • Hormone therapy and risk for cardiovascular disease and death
  • Surrogate markets for disease progression in men with CRPC … READ MORE …

Filed under: Diagnosis, Management, Risk, Treatment | Tagged: , , , , , , , , , , , , | Leave a Comment »

Prostate cancer news reports: Friday, May 22, 2009

Posted on May 22, 2009 by Sitemaster

Today’s news reports cover items on:

  • Gene expression and prostate cancer progression
  • Risk of complications from in-office prostate biopsy
  • Post-RALP voiding function
  • Urinary toxicities after IMRT-SIB
  • Drugs in development for CRPC … READ MORE …

Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: , , , , , , , , , , , | Leave a Comment »

Follow

Get every new post delivered to your Inbox.

Join 827 other followers